 "Torrent Pharmaceuticals, Torrent Pharma, Bio-Pharm, Torrent Pharma buys Bio-Pharm, Torrent Pharma acquisition, drug firm Torrent Pharma, Torrent Pharma US business, USFDA")
Ahmedabad-headquartered Rs 58 billion worth drug firm Torrent Pharmaceuticals on Thursday made its sixth acquisition in the last five years to put its fledgeling US business on a recovery path - it bought a generic pharmaceutical and over the counter (OTC) drugs company Bio-Pharm Inc (BPI) for an undisclosed amount. Market sources peg the deal size at around a few billion rupees and much lesser than Torrent's latest buy Unichem (a Rs 36 billion deal).
The Levittown, Pennsylvania-based company operates in the sector of oral solutions, suspensions and suppositories and has ten approved abbreviated new drug applications (ANDAs) and another
